The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Depression in cancer patients: Pathogenesis, implications and treatment (Review)
Open accessAbstract
pathological sadness may be a normal response to a cancer diagnosis, however, stress beyond the coping mechanisms of patients may result in major depressive disorder. The current review, in addition to the obvious psychosocial elements of depression, explores its biological mechanisms, including tissue damage, inflammatory mediators and the chronic stress response, and how these immune and endocrine pathways may underlie depression in cancer. Possible iatrogenic causes of depression in cancer are also explored. There is a strong need to identify and treat depression in cancer patients in order to increase quality of life and reduce mortality. The most popular clinical and potential future biochemical screening tools for depression in cancer are briefly discussed. The interventions used will vary for every patient, but may include psychosocial therapies or pharmacotherapy; however, a paucity of research on the most effective management of depression in cancer means the optimal combination of therapies is unknown. Selection of antidepressants should be carefully considered, given the common side effects of chemotherapy (such as nausea), and the necessity to avoid serious interactions, including reducing the effectiveness of chemotherapeutic drugs. The possible link between the chronic stress response, which may predispose patients to depression, and the risk of mortality from cancer is also explored. The complex interactions between the endocrine, nervous and immune systems, which continue to be elucidated, may offer the opportunity for the development of more rapid and efficacious treatments for depression in cancer in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Immune-neuro-endocrine interactions: facts and hypotheses.
BESEDOVSKY, H. O., & REY, A. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-64 · Cited by 1,564
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age
Linden, W., Vodermaier, A., MacKenzie, R., & Greig, D. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.025 · Cited by 1,245
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Depression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083 · cited 6×
“Depressed cancer patients are at increased risk of mortality compared with non ‑ depressed patients (5).”
InfluentialDepression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972
A mechanism converting psychosocial stress into mononuclear cell activation
Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P. M., Petrov, D., Ferstl, R., von Eynatten, M., Wendt, T., Rudofsky, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438019100 · Cited by 927
The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death
Sapolsky, R. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00971-9 · Cited by 699
The cholinergic anti-inflammatory pathway
Pavlov, V. A., & Tracey, K. J. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.03.015 · Cited by 622
Osborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/eufn-rv1k-y3tr-fk0l · Cited by 621
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Incidence of Suicide in Persons With Cancer
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8941 · Cited by 608
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
BORGES, S., DESTA, Z., LI, L., SKAAR, T., WARD, B., NGUYEN, A., JIN, Y., STORNIOLO, A., NIKOLOFF, D., & WU, L. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.03.013 · Cited by 487
Giese-Davis, J., Collie, K., Rancourt, K. M. S., Neri, E., Kraemer, H. C., & Spiegel, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4455 · Cited by 458
Musselman, D. L., Miller, A. H., Porter, M. R., Manatunga, A., Gao, F., Penna, S., Pearce, B. D., Landry, J., Glover, S., McDaniel, J. S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1252 · Cited by 445
Holsboer, F., & Ising, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.032 · Cited by 382
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374
Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type
Brintzenhofe-Szoc, K. M., Levin, T. T., Li, Y., Kissane, D. W., & Zabora, J. R. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.4.383 · Cited by 364 · cited 1×
“This mixed symptomatology is very common, with two thirds of cancer patients with depression also expressing clinically significant levels of anxiety (3).”
Depression and degree of acceptance of adjuvant cytotoxic drugs
Colleoni, M., Mandala, M., Peruzzotti, G., Robertson, C., Bredart, A., & Goldhirsch, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02821-x · Cited by 351
Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis
Craft, L. L., VanIterson, E. H., Helenowski, I. B., Rademaker, A. W., & Courneya, K. S. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0634 · Cited by 277
Pain and depression in patients with cancer
Spiegel, D., Sands, S., & Koopman, C. (1994) · Cancer · doi:10.1002/1097-0142(19941101)74:9<2570::aid-cncr2820740927>3.0.co;2-3 · Cited by 272
Chronic Stress and Susceptibility to Skin Cancer
Saul, A. N., Oberyszyn, T. M., Daugherty, C., Kusewitt, D., Jones, S., Jewell, S., Malarkey, W. B., Lehman, A., Lemeshow, S., & Dhabhar, F. S. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji401 · Cited by 245
Evidence‐based treatment of depression in patients with cancer
Li, M., Fitzgerald, P., & Rodin, G. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7372 · Cited by 236 · cited 3×
“The use of conventional antidepressants in patients with terminal cancer may be unwise due to the delayed mode of action of these drugs (12,53,54).”
The American Psychiatric Publishing textbook of psychopharmacology
(2010) · Choice Reviews Online · doi:10.5860/choice.47-4164 · Cited by 233
Assessment of depression among cancer patients: the role of pain, cancer type and treatment
Ciaramella, A., & Poli, P. (2001) · Psycho-Oncology · doi:10.1002/pon.505 · Cited by 231
Behavioral stress accelerates prostate cancer development in mice
Hassan, S., Karpova, Y., Baiz, D., Yancey, D., Pullikuth, A., Flores, A., Register, T., Cline, J. M., D’Agostino, R., Danial, N., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63324 · Cited by 229
Zhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Liu, L., Fiorentino, L., Natarajan, L., Parker, B. A., Mills, P. J., Sadler, G. R., Dimsdale, J. E., Rissling, M., He, F., & Ancoli‐Israel, S. (2009) · Psycho-Oncology · doi:10.1002/pon.1412 · Cited by 220
Feros, D. L., Lane, L., Ciarrochi, J., & Blackledge, J. T. (2013) · Psycho-Oncology · doi:10.1002/pon.2083 · Cited by 216
Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214
Chronic restraint stress attenuates p53 function and promotes tumorigenesis
Feng, Z., Liu, L., Zhang, C., Zheng, T., Wang, J., Lin, M., Zhao, Y., Wang, X., Levine, A. J., & Hu, W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203930109 · Cited by 209
Hopko, D. R., Armento, M. E. A., Robertson, S. M. C., Ryba, M. M., Carvalho, J. P., Colman, L. K., Mullane, C., Gawrysiak, M., Bell, J. L., McNulty, J. K., et al. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0025450 · Cited by 193
Survival and Health Care Utilization in Elderly Medical Inpatients With Major Depression
Koenig, H. G., Shelp, F., Goli, V., Cohen, H. J., & Blazer, D. G. (1989) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1989.tb01249.x · Cited by 192
Felger, J. C., Li, L., Marvar, P. J., Woolwine, B. J., Harrison, D. G., Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.010 · Cited by 176
Predictors of psychosocial adjustment in patients newly diagnosed with gynecological cancer
MISHEL, M. H., HOSTETTER, T., KING, B., & GRAHAM, V. (1984) · Cancer Nursing · doi:10.1097/00002820-198408000-00003 · Cited by 168
Barsevick, A. M., Sweeney, C., Haney, E., & Chung, E. (2002) · Oncology Nursing Forum · doi:10.1188/02.onf.73-87 · Cited by 163
von Essén, L., Enskär, K., Kreuger, A., Larsson, B., & Sjödén, P. (2000) · Acta Paediatrica · doi:10.1111/j.1651-2227.2000.tb01221.x · Cited by 152
Okamura, M., Yamawaki, S., Akechi, T., Taniguchi, K., & Uchitomi, Y. (2005) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi097 · Cited by 149
Biomarkers of depression in cancer patients
Jehn, C. F., Kuehnhardt, D., Bartholomae, A., Pfeiffer, S., Krebs, M., Regierer, A. C., Schmid, P., Possinger, K., & Flath, B. C. (2006) · Cancer · doi:10.1002/cncr.22294 · Cited by 139
The prevalence and pharmacotherapy of depression in cancer patients
Ng, C. G., Boks, M. P. M., Zainal, N. Z., & de Wit, N. J. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.034 · Cited by 138 · cited 3×
“The use of conventional antidepressants in patients with terminal cancer may be unwise due to the delayed mode of action of these drugs (12,53,54).”
InfluentialAllen, R., Newman, S. P., & Souhami, R. L. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00176-7 · Cited by 131
Drug-Induced Depression: A Systematic Review to Inform Clinical Practice
Patten, S. B., & Barbui, C. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000077739 · Cited by 130
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients
Lutgendorf, S. K., Lamkin, D. M., DeGeest, K., Anderson, B., Dao, M., McGinn, S., Zimmerman, B., Maiseri, H., Sood, A. K., & Lubaroff, D. M. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.012 · Cited by 126 · cited 1×
“In ovarian cancer patients, depressed and anxious moods were associated with significantly impaired T helper 1 cell levels, cytotoxic T lymphocyte levels and interferon ‑ γ (INF ‑ γ ) secretion in both the microenvironment of the tumour and peripheral blood (48).”
Laoutidis, Z. G., & Mathiak, K. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-140 · Cited by 126
The effect of St John’s wort extracts on CYP3A: a systematic review of prospective clinical trials
Whitten, D. L., Myers, S. P., Hawrelak, J. A., & Wohlmuth, H. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02755.x · Cited by 122
Nadjar, A., Bluthé, R.-M., May, M. J., Dantzer, R., & Parnet, P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300755 · Cited by 120
Psychostimulants for Depression in Hospitalized Cancer Patients
Olin, J., & Masand, P. S. (1996) · Psychosomatics · doi:10.1016/s0033-3182(96)71599-2 · Cited by 119
Plasma Tryptophan and Five Other Amino Acids in Depressed and Normal Subjects
DeMyer, M. K. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780310042003 · Cited by 118
Relaxation and Imagery for Anxiety and Depression Control in Community Patients With Advanced Cancer
Sloman, R. (2002) · Cancer Nursing · doi:10.1097/00002820-200212000-00005 · Cited by 109
Caraci, F., Crupi, R., Drago, F., & Spina, E. (2011) · Current Drug Metabolism · doi:10.2174/138920011795713706 · Cited by 81
Boyes, A., Girgis, A., Zucca, A. C., & Lecathelinais, C. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02479.x · Cited by 80
Somatic Symptoms for Diagnosing Major Depression in Cancer Patients
Akechi, T., Nakano, T., Akizuki, N., Okamura, M., Sakuma, K., Nakanishi, T., Yoshikawa, E., & Uchitomi, Y. (2003) · Psychosomatics · doi:10.1176/appi.psy.44.3.244 · Cited by 77
Maes, M. H. J., Meltzer, H. Y., Stevens, W. J., Calabrese, J. R., & Cosyns, P. R. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90079-5 · Cited by 69
Intravenous Ketamine “Burst” for Refractory Depression in a Patient with Advanced Cancer
Stefanczyk-Sapieha, L., Oneschuk, D., & Demas, M. (2008) · Journal of Palliative Medicine · doi:10.1089/jpm.2008.9828 · Cited by 61
Clinically relevant drug interactions between anticancer drugs and psychotropic agents
Yap, K. Y., Tay, W. L., Chui, W., & Chan, A. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2009.01113.x · Cited by 61
Perceptions of the “Mind-Cancer” Relationship Among the Public, Cancer Patients, and Oncologists
Lemon, J., Edelman, S., & KIDMAN, A. D. (2003) · Journal of Psychosocial Oncology · doi:10.1300/j077v21n04_03 · Cited by 24
Antidepressant medication in patients with advanced cancer--an observational study
Lloyd-Williams, M., Payne, S., Reeve, J., & Kolamunnage Dona, R. (2013) · QJM · doi:10.1093/qjmed/hct133 · Cited by 20 · cited 1×
“An observational study supported this notion, concluding that currently prescribed antidepressants have little effect on improving depression in terminally ill depressed cancer patients, as measured by depression scores (56).”
Pasquini, M., Speca, A., Mastroeni, S., Chiaie, R. D., Sternberg, C. N., & Biondi, M. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.01.009 · Cited by 19
PREVALENCE AND SCREENING OF PSYCHIATRIC DISORDER IN PATIENTS WITH EARLY STAGE BREAST CANCER
Sneeuw, K. C. A., Aaronson, N. K., & Van Wouwe, M. C. C. (1993) · Cited by 14
Experimental and Clinical Pharmacology: The new antidepressants - mechanisms of action
Norman, T. R. (1999) · Australian Prescriber · doi:10.18773/austprescr.1999.094 · Cited by 7
Cited by
Depression and anxiety in patients with cancer
Pitman, A., Suleman, S., Hyde, N., & Hodgkiss, A. (2018) · BMJ · doi:10.1136/bmj.k1415 · Cited by 871
Wang, Y.-H., Li, J.-Q., Shi, J.-F., Que, J.-Y., Liu, J.-J., Lappin, J. M., Leung, J., Ravindran, A. V., Chen, W.-Q., Qiao, Y.-L., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0595-x · Cited by 885
Niedzwiedz, C. L., Knifton, L., Robb, K. A., Katikireddi, S. V., & Smith, D. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-6181-4 · Cited by 756
Depression and Anxiety in Patients With Cancer: A Cross-Sectional Study
Naser, A. Y., Hameed, A. N., Mustafa, N., Alwafi, H., Dahmash, E. Z., Alyami, H. S., & Khalil, H. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.585534 · Cited by 281
Pitsillou, E., Bresnehan, S. M., Kagarakis, E. A., Wijoyo, S. J., Liang, J., Hung, A., & Karagiannis, T. C. (2020) · Molecular Biology Reports · doi:10.1007/s11033-019-05129-3 · Cited by 206
Metadata
- Authors
- SMITH, H. R.
- Venue
- Oncology Letters
- Publisher
- Spandidos Publications
- Published
- 2015-02-09
- Volume
- 9
- Issue
- 4
- Pages
- 1509-1514
- ISSN
- 1792-1074 (ISSN-L)
- 1792-1082
- OpenAlex
- W2013263319
- Cited by
- 478
- References
- 71
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.